TCN2 and systemic lupus erythematosus: More importantly, TCN2 expression in all types of monocytes was notably increased in patients with high disease activity compared to those with inactive SLE (Figure 1C), implying the potential involvement of TCN2 in SLE progression through the regulation of monocyte function.